Crizanlizumab Versus Placebo, with or without Hydroxyurea/Hydroxycarbamide, in Adolescent and Adult Patients with Sickle Cell Disease and Vaso-Occlusive Crises: A Randomized, Double-Blind, Phase III Study (STAND)

Abboud M. R., Howard J., Cancado R., Smith W. R., Guvenc B., Espurz N., ...More

vol.134 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 134
  • Çukurova University Affiliated: Yes